PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+6.17%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$918M
AUM Growth
+$918M
(-8%)
Cap. Flow
-$47.2M
Cap. Flow
% of AUM
-5.14%
Top 10 Holdings %
Top 10 Hldgs %
48.67%
Holding
156
New
37
Increased
25
Reduced
25
Closed
31
Top Buys
| 1 |
AFMD
Affimed
AFMD
|
$63M |
| 2 |
OTIC
Otonomy, Inc.
OTIC
|
$20.1M |
| 3 |
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
|
$12.2M |
| 4 |
Arrowhead Research
ARWR
|
$12.2M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
$11M |
Top Sells
| 1 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
$37M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$25.8M |
| 3 |
TARO
Taro Pharmaceutical Industries Ltd.
TARO
|
$24.7M |
| 4 |
SHPG
Shire pic
SHPG
|
$21.2M |
| 5 |
Insmed
INSM
|
$15.7M |
Sector Composition
| 1 | Healthcare | 88.14% |
| 2 | Financials | 0.2% |
| 3 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NEPT
26
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
| $9.07M | 0.92% |
4,786
| – | – |
|
|
AGN
27
DELISTED
ALLERGAN INC
AGN
| $8.91M | 0.9% |
50,000
| – | – |
|
|
AVDL
28
Avadel Pharmaceuticals
AVDL
$1.45B
| $8.73M | 0.88% |
610,000
-190,000
| -24% | -$2.72M |
|
29
Sangamo Therapeutics
SGMO
$161M
| $8.63M | 0.87% |
800,000
| – | – |
|
|
30
Insmed
INSM
$30.3B
| $7.83M | 0.79% |
600,000
-1,200,000
| -67% | -$15.7M |
|
|
EPZM
31
DELISTED
Epizyme, Inc
EPZM
| $7.7M | 0.78% |
283,890
+241,288
| +566% | +$6.54M |
|
32
Heron Therapeutics
HRTX
$204M
| $7.38M | 0.75% |
885,352
-749,203
| -46% | -$6.24M |
|
33
Prothena Corp
PRTA
$452M
| $6.65M | 0.67% |
300,000
-183,162
| -38% | -$4.06M |
|
|
SAGE
34
DELISTED
Sage Therapeutics
SAGE
| $6.57M | 0.67% |
+208,676
| New | +$6.57M |
|
|
LCI
35
DELISTED
Lannett Company, Inc.
LCI
| $6.15M | 0.62% |
+33,642
| New | +$6.15M |
|
|
ASXC
36
DELISTED
Asensus Surgical, Inc.
ASXC
| $5.72M | 0.58% |
100,919
+919
| +0.9% | +$52.1K |
|
|
AGTC
37
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $5.53M | 0.56% |
296,978
+150,000
| +102% | +$2.79M |
|
|
AVNR
38
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $5.48M | 0.56% |
+460,000
| New | +$5.48M |
|
|
AERI
39
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $5.44M | 0.55% |
1,121,951
| – | – |
|
40
Larimar Therapeutics
LRMR
$337M
| $5.4M | 0.55% |
+22,917
| New | +$5.4M |
|
|
BDSI
41
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $5.23M | 0.53% |
306,000
-394,000
| -56% | -$6.73M |
|
|
TRVN
42
DELISTED
Trevena, Inc.
TRVN
| $4.94M | 0.5% |
1,232
| – | – |
|
|
PCYC
43
DELISTED
PHARMACYCLICS INC
PCYC
| $4.7M | 0.48% |
+40,000
| New | +$4.7M |
|
44
MacroGenics
MGNX
$121M
| $4.47M | 0.45% |
213,703
-218,100
| -51% | -$4.56M |
|
45
Tenet Healthcare
THC
$16.5B
| $4.01M | 0.41% |
+67,500
| New | +$4.01M |
|
|
THOR
46
DELISTED
THORATEC CORPORATION
THOR
| $3.94M | 0.4% |
+147,501
| New | +$3.94M |
|
|
SPNC
47
DELISTED
Spectranetics Corp
SPNC
| $3.68M | 0.37% |
138,371
-104,983
| -43% | -$2.79M |
|
|
AGN
48
DELISTED
Allergan plc
AGN
| $3.62M | 0.37% |
+15,000
| New | +$3.62M |
|
|
CMRX
49
DELISTED
Chimerix, Inc.
CMRX
| $3.54M | 0.36% |
128,000
-20,000
| -14% | -$552K |
|
50
Vericel Corp
VCEL
$1.69B
| $3.14M | 0.32% |
+1,100,000
| New | +$3.14M |
|